China Pharma Holdings (CPHI) Shares Outstanding (Weighted Average) (2010 - 2026)

China Pharma Holdings has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $25.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 684.88% year-over-year to $25.6 million; the trailing twelve-month figure through Mar 2026 stood at $25.6 million (up 684.88% YoY), and the FY2025 full-year result was $4.3 million, up 145.73% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $25.6 million, up from $4.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $25.6 million in Q1 2026, with the low at $1.3 million in Q1 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $4.4 million across 5 years, with a median of $3.3 million in 2025.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) tumbled 89.48% — and 2026, when it jumped 684.88%.
• China Pharma Holdings' Shares Outstanding (Weighted Average) stood at $4.8 million in 2022, then retreated by 29.41% to $3.4 million in 2023, then slumped by 48.39% to $1.7 million in 2024, then surged by 145.73% to $4.3 million in 2025, then soared by 496.58% to $25.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $25.6 million (Q1 2026), $4.3 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.